Issues Impacting Commercial Decision Making and Patient Access in the Biopharmaceutical Market

Now more than ever, manufacturers are looking at ways for integrating reimbursement strategies earlier in the product development cycle. Even if a product is differentiated clinically, we need to distinguish it from competitors for better reimbursement positioning.

This is a first of its kind webinar with key industry experts discussing the following:

• Global Health Policy Changes
• U.S. Health Policy Changes
• U.S. Payer Perspectives

Hear from the following experts:

Grant P. Bagley, MD, JD
Senior Advisor, HillCo HEALTH
Dr. Bagley has nearly 30 years of experience in the healthcare field with a deep and sophisticated understanding of healthcare policy issues and regulatory programs. He works with clients on Centers for Medicare & Medicaid Services (CMS) and Food and Drug Administration (FDA) matters, as well as healthcare reform and legislative initiatives.

Richard Morton
Vice President, Commercialization Strategy, PAREXEL
Dr. Morton focuses on defining strategy and implementing integrated development and commercialization work streams within Europe and has extensive experience in a wide variety of therapeutic areas. He works closely with clinical, medical, health outcomes and marketers as part of core strategic teams with European, US and Global pharmaceutical clients.

Gary Owens, MD
President, Gary Owens Associates
As president of Gary Owens Associates, Dr. Owens provides reimbursement advice to manufacturers of new technology, including drugs, devices and biotechnology products. He has over 20 years of medical management experience with healthcare organizations including management of pharmacy services and chairing the Pharmacy and Therapeutics Committee for over 15 years.

Moderator:

Charles A. (Chuck) Stevens, JD, MBA
Vice President & General Manager, Commercialization Strategy PAREXEL
Mr. Stevens is responsible for leading commercialization strategy including managing all reimbursement, market access and commercial strategy consulting, tactical reimbursement support help lines and PAP's (Patient Assistance Programs) designed to provide workable solutions to support commercial success and patient access to therapy.

Registration is complimentary.

Click here to register and view the on-demand version of the webinar.

This webinar is open exclusively to pharmaceutical and biotechnology companies.